Howard L. Sofen
Impact in
- Dermatology top 0.1%
- Dermatology and Skin Diseases
- Immunology top 0.5%
- Psoriasis: Treatment and Pathogenesis
Papers in
- Immunology 73
- Psoriasis: Treatment and Pathogenesis 69
- Dermatology 24
- Dermatology and Skin Diseases 20
- Co-authors
- Kim Alexander Papp (24 shared papers)Andrew Blauvelt (33 shared papers)Kenneth B. Gordon (9 shared papers)Mark Lebwohl (26 shared papers)Mary Flack (4 shared papers)Yves P. Poulin (7 shared papers)Bruce E Strober (16 shared papers)Peter Anthony Foley (6 shared papers)
- Journals
- Journal of the American Academy of Dermatology (22 papers)Journal of the European Academy of Dermatology and Venereology (13 papers)British Journal of Dermatology (10 papers)JAMA Dermatology (5 papers)Journal of Dermatological Treatment (5 papers)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Howard L. Sofen
99 papers receiving 5.0k citations
Howard L. Sofen's Hit Papers
Peers
Comparison fields: 5 of 96
- Dermatology 2.1k
- Immunology 2.9k
- Immunology and Allergy 507
- Rheumatology 704
- Pathology and Forensic Medicine 479
Countries citing papers authored by Howard L. Sofen
This map shows the geographic impact of Howard L. Sofen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard L. Sofen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard L. Sofen more than expected).
Fields of papers citing papers by Howard L. Sofen
This network shows the impact of papers produced by Howard L. Sofen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard L. Sofen. The network helps show where Howard L. Sofen may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard L. Sofen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials Hit paper breakdown → | 2018 | 535 |
| 2 | Efficacy and safety of dupilumab in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical treatments: a randomised, placebo-controlled, dose-ranging phase 2b trial Hit paper breakdown → | 2015 | 489 |
| 3 | 2017 | 443 | |
| 4 | 2015 | 317 | |
| 5 | 2014 | 287 | |
| 6 | Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE) Hit paper breakdown → | 2018 | 282 |
| 7 | 2014 | 253 | |
| 8 | 2012 | 236 | |
| 9 | Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial Hit paper breakdown → | 2022 | 225 |
| 10 | 2012 | 181 | |
| 11 | 2014 | 134 | |
| 12 | 2019 | 113 | |
| 13 | 2018 | 108 | |
| 14 | Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis Hit paper breakdown → | 2023 | 98 |
| 15 | 2011 | 96 | |
| 16 | 2013 | 92 | |
| 17 | 2023 | 70 | |
| 18 | 2011 | 64 | |
| 19 | 2015 | 64 | |
| 20 | 2017 | 59 |
About Howard L. Sofen
Howard L. Sofen is a scholar working on Immunology, Dermatology, Pediatrics, Perinatology and Child Health, Immunology and Allergy and Rheumatology, having authored 105 papers that have together received 5.2k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (69 papers), Dermatology and Skin Diseases (20 papers), Pharmaceutical studies and practices (13 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Urticaria and Related Conditions (5 papers), Cytokine Signaling Pathways and Interactions (5 papers), Synthesis and biological activity (4 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Dermatology (2.1k citations), Immunology (2.9k citations), Immunology and Allergy (507 citations), Rheumatology (704 citations) and Pathology and Forensic Medicine (479 citations). Howard L. Sofen has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kim Alexander Papp, Andrew Blauvelt, Kenneth B. Gordon, Mark Lebwohl, Mary Flack, Yves P. Poulin, Bruce E Strober, Peter Anthony Foley, Stephen Keith Tyring and Matthias Augustin. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, JAMA Dermatology and Journal of Dermatological Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.